<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163318">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02134496</url>
  </required_header>
  <id_info>
    <org_study_id>H-1-2014-012</org_study_id>
    <nct_id>NCT02134496</nct_id>
  </id_info>
  <brief_title>PACU Discharge Without Motorfunction Assessment After Spinal Anaesthesia</brief_title>
  <official_title>PACU Discharge Without Motorfunction Assessment After Spinal Anaesthesia for Total Hip or Knee Arthroplasty - a Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <authority>Denmark: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates the safety of discharge from the Post-Anesthesia Care Unit (PACU)
      without assessment of motorfunction after spinal anesthesia for total hip- or knee
      replacement. This is an randomized controlled trial between two groups with assessment of
      normal (Aldrete) PACU discharge criteria with or without assessment of the motorfunction.
      The study hypothesis is that it is safe to be discharged from the PACU to a ward without
      assessment of motor function.T The main outcome is length of hospial stay (LOS) in days and
      re-admission within the first 90 days after surgery .

      Secondary outcomes include adverse events up to 24 hours after surgery, and minuttes spent
      in the PACU after surgery.

      Participants will be monitores for adverse events for the first 24 hours after surgery and
      reported. The total number of minuttes spent in the PACU will be recorded and reported.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Please see section above
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Lenght of stay (in days) or 90 day readmissions</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The main outcome is a compund measure of the duration of hospitalization after operation )measured in days, and named Length of Stay LOS) adn/or re-admission within the first 90 days after discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>24 hours postooperatively</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Any event that results in a physicians assessment of the patient, not including regular rounds during the first 24 hours after surgery.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time to discharge from PACU</measure>
    <time_frame>12 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time from arrival to discharge i PACU measured in minuttes</description>
  </other_outcome>
  <other_outcome>
    <measure>Discharge readiness before leaving the operating theater</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>How many patients fulfilled the PACU discahrge criteria at the time they were leaving the operating theater</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Osteoarthritis Susceptibility 3</condition>
  <arm_group>
    <arm_group_label>no assessment of motorfunction in PACU</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no assessment of motorfunction after spinal anesthesia in PACU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>motorfunction assessment in PACU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Assesment of motorfunction after spinal anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>assessment of motorfunction in PACU</intervention_name>
    <description>assessment of motorfunction in PACU after spinal anesthesia</description>
    <arm_group_label>motorfunction assessment in PACU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 yr or more

          -  primary unilateral total hip or knee arthroplasty

          -  spinal anesthesia

        Exclusion Criteria:

          -  intraoperative conversion to general anesthesia

          -  intraoperative bleeding exceeding 750 ml.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henrik Kehlet, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eske K Aasvang, M.D., DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gentofte Hospital</name>
      <address>
        <city>Gentofte</city>
        <state>International</state>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vejle Sygehus</name>
      <address>
        <city>Vejle</city>
        <state>International</state>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Farsø Sygehus</name>
      <address>
        <city>Farsø</city>
        <zip>4640</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 8, 2014</lastchanged_date>
  <firstreceived_date>April 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Eske Kvanner Aasvang</investigator_full_name>
    <investigator_title>M.D. DMSci</investigator_title>
  </responsible_party>
  <keyword>hip</keyword>
  <keyword>knee</keyword>
  <keyword>arthroplasty</keyword>
  <keyword>spinal</keyword>
  <keyword>anesthesia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
